THE GENE CODING FOR THE B-CELL SURFACE PROTEIN CD19 IS LOCALIZED ON HUMAN-CHROMOSOME 16P11

被引：0
|
作者：
STAPLETON, P [1 ]
KOZMIK, Z [1 ]
WEITH, A [1 ]
BUSSLINGER, M [1 ]
机构：
[1] RES INST MOLEC PATHOL,A-1030 VIENNA,AUSTRIA
来源：
HUMAN GENETICS | 1995年 / 95卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
The CD19 gene codes for one of the earliest markers of the human B cell lineage and is a target for the B lymphoid-specific transcription factor BSAP (Pax-5). The transmembrane protein CD19 has been implicated in controlling proliferation of mature B lymphocytes by modulating signal transduction through the antigen receptor. In this study, we have employed Southern blot and fluorescence in situ hybridization analyses to localize the CD19 gene to human chromosome 16p11.
引用
收藏
页码：223 / 225
页数：3
相关论文
共 50 条
  • [1] HpaII polymerase chain reaction restriction fragment length polymorphism in the human CD19 gene on 16p11
    Thunberg, U
    Gidlöf, C
    Bånghagen, M
    Sällström, JF
    Sundström, C
    Tötterman, T
    HUMAN HEREDITY, 1998, 48 (04) : 230 - 231
  • [2] CD19 REGULATION OF HUMAN B-CELL RESPONSES - B-CELL PROLIFERATION AND ANTIBODY SECRETION ARE INHIBITED OR ENHANCED BY LIGATION OF THE CD19 SURFACE GLYCOPROTEIN DEPENDING ON THE STIMULATING SIGNAL USED
    CALLARD, RE
    RIGLEY, KP
    SMITH, SH
    THURSTAN, S
    SHIELDS, JG
    JOURNAL OF IMMUNOLOGY, 1992, 148 (10): : 2983 - 2987
  • [3] A human early B-cell factor-like protein participates in the regulation of the human CD19 promoter
    Gisler, R
    Åkerblad, P
    Sigvardsson, M
    MOLECULAR IMMUNOLOGY, 1999, 36 (15-16) : 1067 - 1077
  • [4] A PANEL OF CD19 DEFICIENT B-CELL LINES PROVIDES INSIGHTS INTO THE MECHANISMS REGULATING CD19 GENE-TRANSCRIPTION
    RIVA, A
    KEHRL, JH
    FASEB JOURNAL, 1994, 8 (05): : A788 - A788
  • [5] A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
    Cardarelli, Pina M.
    Rao-Naik, Chetana
    Chen, Sharline
    Huang, Haichun
    Pham, Amie
    Moldovan-Loomis, Maria-Cristina
    Pan, Chin
    Preston, Ben
    Passmore, David
    Liu, Jie
    Kuhne, Michelle R.
    Witte, Alison
    Blanset, Diann
    King, David J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (02) : 257 - 265
  • [6] A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
    Pina M. Cardarelli
    Chetana Rao-Naik
    Sharline Chen
    Haichun Huang
    Amie Pham
    Maria-Cristina Moldovan-Loomis
    Chin Pan
    Ben Preston
    David Passmore
    Jie Liu
    Michelle R. Kuhne
    Alison Witte
    Diann Blanset
    David J. King
    Cancer Immunology, Immunotherapy, 2010, 59 : 257 - 265
  • [7] DEVELOPMENT OF HUMAN B-CELL LINES DEFICIENT IN CD19, CD20, OR CD22
    WILSON, GL
    RIVA, A
    KEHRL, JH
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A99 - A99
  • [8] Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy
    Libert, Diane
    Yuan, Constance M.
    Masih, Katherine E.
    Galera, Pallavi
    Salem, Dalia
    Shalabi, Haneen
    Yates, Bonnie
    Delbrook, Cindy
    Shern, Jack F.
    Fry, Terry J.
    Khan, Javed
    Stetler-Stevenson, Maryalice
    Shah, Nirali N.
    LEUKEMIA, 2020, 34 (11) : 3064 - 3069
  • [9] Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy
    Diane Libert
    Constance M. Yuan
    Katherine E. Masih
    Pallavi Galera
    Dalia Salem
    Haneen Shalabi
    Bonnie Yates
    Cindy Delbrook
    Jack F. Shern
    Terry J. Fry
    Javed Khan
    Maryalice Stetler-Stevenson
    Nirali N. Shah
    Leukemia, 2020, 34 : 3064 - 3069
  • [10] Immunotherapy of Hematological Malignancies of Human B-Cell Origin with CD19 CAR T Lymphocytes
    Khvorost, Darya
    Kendall, Brittany
    Jazirehi, Ali R.
    CELLS, 2024, 13 (08)
12345